Synthesis, molecular docking and antimicrobial evaluation of octadecanoic acid [4-(5-phenyl-4,5-dihydro-1H-pyrazol-3-yl)phenyl]-amide pyrazoline derivatives
Abstract
A new series of octadecanoic acid [4-(5-phenyl-4,5-dihydro-1H-pyrazol-3-yl)phenyl]-amide pyrazoline derivatives were designed synthesized, and characterized by spectral analysis (IR, MS, 1H-NMR, 13C-NMR). The compounds were screened for in vitro antibacterial activity against Escherichia coli and Staphylococcus aureus. All the compounds exhibited significant antibacterial activity with minimum inhibitory concentrations ranging from 1.2 to 2.5 mg/mL. The newly synthesized compounds were also found to have good anti-fungal activity against Fusarium oxysporum and Penicillium italicum, with all the compounds showing MIC of 2.5 mg/mL for both the fungal strains. Molecular docking studies were also incorporated to elucidate the possible interactions of the synthesized compounds with bacterial and fungal proteins.
Keywords:
Synthesis, Pyrazoline derivatives, Antimicrobial activity, Molecular dockingDOI
https://doi.org/10.25004/IJPSDR.2021.130507References
Dias D, Pacheco BS, Cunico W, Pizzuti L, Pereira CMP. Recent Advances on the Green Synthesis and Antioxidant Activities of Pyrazoles. Mini Rev Med Chem. 2014;14(13): 1078-92. Available from: doi.org/10.2174/138955751566615010110 2606
A lam J, A lam O, A lam P, Naim MJ. A Rev iew on P y razole Chemical Entity and Biological Activity. Int. J. Pharm. Sci. Res. 2015;6(12):1433–1442.
Kumar V, Kaur K, Kumar G, Kumar A. European Journal of Medicinal Chemistry Pyrazole Containing Natural Products : Synthetic Preview and Biological Signi Fi Cance. Eur. J. Med. Chem. 2013;69:735–753. Available from: doi.org/10.1016/j.ejmech.2013 .08.053
Venância J, Fazolin P, Gabriella A, Miguita C, Silva M, Boechat N, Maria A, Bernardino R. Bioorganic & Medicinal Chemistry Recently Reported Biological Activities of Pyrazole Compounds. Bioorg. Med. Chem. 2017;25:5891–5903. Available from: doi.org/10.1016/j. bmc.2017.09.035
Ardiansah B. Recent Reports on Pyrazole-Based Bioactive Compounds as Candidate for Anticancer Agents. Asian J Pharm Clin Res. 2018;10(12):1–8. Available from: doi.org/10.22159/ajpcr.2017. v10i12.22065
Kuma r K A , Jaya roopa P. Sy nt het ic St rateg ies a nd T heir Pharmaceutical Applications-An Overview. Int. J. Pharmtech Res. 2015;5(4):1473–1486.
Taylor, P.; Fustero, S.; Simón-fuentes, A.; Sanz-cervera, J. F.; Fustero, S.; Sim, A.; Sanz-cervera, J. F. Recent Advances in the Synthesis of Pyrazoles. Org Prep Proced Int. 2009; 41:253–290. Available from: doi.org/10.1080/ 0030 4940903077832
Naim MJ, Alam O, Nawaz F, Alam J, Alam P. Current Status of Pyrazole and Its Biological Activities. J. Pharm. Bioallied Sci. 2016;8(1):2–17. Available from: doi.org/ 10.4103/0975-7406.171694
Mert S, Kasimogullari R, Ok S. A Short Review on Pyrazole Derivatives and Their Applications. J. Postdr. Res. 2014;2(4): 64–72.
Yerragunta V, Suman D, Anusha V. Pyrazole and Its Biological Activity. PharmaTutor 2014;2(1):40–48.
Yildirim I. Carboxylic Acid Methanol Solvate. Acta Cryst. 2005;61:256– 258. Available from: doi.org/10.1107/S1600536804034348
Pal D, Saha S. Importance of Pyrazole Moiety in the Field of Cancer. Int J Pharm Pharm Sci. 2015;4(2):98–104.
Küçükgüzel SG, enkardes SS. European Journal of Medicinal Chemistry Recent Advances in Bioactive Pyrazoles. Eur. J. Med. Chem. 2015;97:86–815. Available from: doi.org/10.1016/j. ejmech.2014.11.059
Salotra R, Utreja D, Sharma P. A Convenient One-Pot Synthesis of Chalcones and Their Derivatives and Their Antimicrobial Activity. Russ. J. Org. Chem. 2020;56(12):2207–2211. Available from: doi. org/10.1134/S1070428020120258
Lafitte D, Tsvetkov PO, Makarov AA, Klich M, Deprez P, Moras D, Briand C, Gilli R, Cedex RV, Recei V. DNA Gyrase Interaction with Coumarin-Based Inhibitors: The Role of the Hydroxybenzoate Isopentenyl Moiety and the 5 ′-Methyl Group of the Noviose. Biochemistry. 2002;41(23):7217–7223. Available from: doi. org/10.1021/bi0159837
Li X, Hilgers M, Cunningham M, Chen Z, Trzoss M, Zhang J, Kohnen L, Lam T, Creighton C, Gc K. Bioorganic & Medicinal Chemistry Letters Structure-Based Design of New DHFR-Based Antibacterial Agents. Bioorg. Med. Chem. Lett. 2011;21(18): 5171–5176. Available from: doi.org/10.1016/j.bmcl.2011.07.059
Bharali P, Saikia JP, Ray A, Konwar BK. Rhamnolipid (RL) from Pseudomonas Aeruginosa OBP1 : A Novel Chemot a xis and Antibacterial Agent. Colloids Surfaces B Biointerfaces. 2013;103:502– 509. Available from: doi.org/10.1016/j.colsurfb.2012.1 0.064
Richa K, Karmaker R, Ao T, Longkumer N, Singha UB. Rationale for Antioxidant Interaction Studies of 4-Bromo-1-Isothiocyanato-2- Me t hy lb en z ene – A n E x p er iment a l a nd C omput at ion a l Investigation. Chem. Phys. Lett. 2020;753:137611. Available from: doi.org/10.1016/j.cplett.2020.137611
Abo-salem, HM, Abdel-aziem A, Islam IE, Yossef MM, El-sawy ER. Sythesis, antimicrobial activity and molecular docking study of some new N-benzyl and N-benzoyl-3-indolyl heterocycles. Int. J. Pharm. Pharm. Sci. 2016;8(9):164–166. Available from: doi. org/10.22159/ijpps.2016v8i9.13184
Published
Abstract Display: 532 
PDF Downloads: 488 
